contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


i-tech-announces-a-one-year-extension-of-the-current-eu-approval-for-selektope-medetomidine

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

I-tech är verksamt inom marinteknik. Bolaget bedriver forskning och utveckling av substansmedel som hämmar marin påväxt på fartygsskrov. Utöver kan produkterna användas för olika marina installationer inom fiskodling och offshore. Kunderna återfinns inom den marina färgindustrin och bland övriga aktörer inom sjöfartsindustrin. I-Tech grundades 2000 och har sitt huvudkontor i Mölndal.

I-tech

I-Tech AB, developers of the innovative antifouling technology Selektope, announce that the current approval for Selektope (Medetomidine) in the European Union has been extended by one year....

<div class="mfn-preamble"><p><strong>I-Tech AB, developers of the innovative antifouling technology Selektope, announce that the current approval for Selektope (Medetomidine) in the European Union has been extended by one year. This extension is part of the normal procedures as the EU Commission continues its thorough re-registration process.</strong></p></div><div class="mfn-body"><p>The re-registration process in the EU involves a comprehensive review to ensure that all substances meet stringent safety and environmental standards. As part of this process, a public consultation was conducted, during which I-Tech received substantial support from various stakeholders. This positive feedback underscores the confidence in Selektope's efficacy and safety.</p><p>While the EU Commission's decision is taking longer than initially anticipated, I-Tech views this extension positively.</p><p>I-Tech´s CEO, Markus Jönsson comments:</p><blockquote>“The new extension reflects the importance of a well-considered decision that takes into account all public consultation opinions. We believe that this careful approach will ultimately benefit both the environment and the maritime industry. We keep working actively on informing decision makers and interest groups about why Selektope is important for use in the EU and we stay hopeful that member states will reach a positive decision by the end of 2025.”</blockquote></div><div class="mfn-footer mfn-9b1f7e1523ba"><p><strong class="mfn-heading-1">Contacts</strong><br>Markus Jönsson, CEO<br>M: +46729-77 96 25<br>E: <a rel="noopener" href="mailto:mailto;markus.jonsson@i-tech.se">markus.jonsson@i-tech.se</a></p></div><div class="mfn-footer mfn-about mfn-4fb4263696ed"><p><strong class="mfn-heading-1">About I-Tech AB</strong><br>I-Tech is a biotechnology company that has developed the antifouling technology Selektope®, an active substance that prevents barnacle attachment on submerged surfaces such as ships and boat hulls. By increasing the anti-barnacle performance in marine paint systems (e.g. antifouling coatings), fuel and maintenance costs are reduced ang vessel energy efficiency improved. I-Tech has obtained the necessary regulatory approvals for Selektope® and has several of the world's largest manufacturers of marine antifouling coatings as customers. The company's share is listed for trading on&nbsp;Nasdaq First North Growth Market&nbsp;in Stockholm. The Company’s Certified Adviser is DNB Carnegie Investment Bank AB. For more information visit our website&nbsp;<a rel="noopener" href="http://www.i-tech.se.">www.i-tech.se</a>.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/ece25b4a-e8c5-45ae-8ce7-8f15bcb773be/i-tech-announces-a-one-year-extension-of-the-current-eu-approval-for-selektope-medetomidine.pdf" class="mfn-generated mfn-primary">I-Tech announces a one year extension of the current EU Approval for Selektope (Medetomidine)</a></p></div>

I-Tech announces a one year extension of the current EU Approval for Selektope (Medetomidine)